Evidence mapPaperPMID 32084246Full record

ArticlePLoS pathogens2020

Single-cell glycolytic activity regulates membrane tension and HIV-1 fusion.

Charles A Coomer, Irene Carlon-Andres, Maro Iliopoulou, Michael L Dustin, Ewoud B Compeer, Alex A Compton, Sergi Padilla-Parra

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Immuno-cell metabolic changes in HIV-1 infection.Infectious diseases & immunity · 2025
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Spatial organization of lysosomal exocytosis relies on membrane tension gradients.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Charles A CoomerCellular Imaging Group, Wellcome Centre Human Genetics, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-2523-6485
Irene Carlon-AndresCellular Imaging Group, Wellcome Centre Human Genetics, University of Oxford, Oxford, United Kingdom.
Maro IliopoulouCellular Imaging Group, Wellcome Centre Human Genetics, University of Oxford, Oxford, United Kingdom.
Michael L DustinKennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-4983-6389
Ewoud B CompeerKennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-3050-7633
Alex A ComptonHIV Dynamics and Replication Program, National Cancer Institute, Frederick, Maryland, United States of America.ORCID 0000-0002-7508-4953
Sergi Padilla-ParraCellular Imaging Group, Wellcome Centre Human Genetics, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-8010-9481
Centre for Human Genetics · GBUniversity of Oxford · GBNational Cancer Institute · US

Funding

Wellcome TrustWellcome Trust 100262Z/12/ZWellcome Trust 203141
6 · The paper itself

Abstract

There has been resurgence in determining the role of host metabolism in viral infection yet deciphering how the metabolic state of single cells affects viral entry and fusion remains unknown. Here, we have developed a novel assay multiplexing genetically-encoded biosensors with single virus tracking (SVT) to evaluate the influence of global metabolic processes on the success rate of virus entry in single cells. We found that cells with a lower ATP:ADP ratio prior to virus addition were less permissive to virus fusion and infection. These results indicated a relationship between host metabolic state and the likelihood for virus-cell fusion to occur. SVT revealed that HIV-1 virions were arrested at hemifusion in glycolytically-inactive cells. Interestingly, cells acutely treated with glycolysis inhibitor 2-deoxyglucose (2-DG) become resistant to virus infection and also display less surface membrane cholesterol. Addition of cholesterol in these in glycolytically-inactive cells rescued the virus entry block at hemifusion and enabled completion of HIV-1 fusion. Further investigation with FRET-based membrane tension and membrane order reporters revealed a link between host cell glycolytic activity and host membrane order and tension. Indeed, cells treated with 2-DG possessed lower plasma membrane lipid order and higher tension values, respectively. Our novel imaging approach that combines lifetime imaging (FLIM) and SVT revealed not only changes in plasma membrane tension at the point of viral fusion, but also that HIV is less likely to enter cells at areas of higher membrane tension. We therefore have identified a connection between host cell glycolytic activity and membrane tension that influences HIV-1 fusion in real-time at the single-virus fusion level in live cells.

Indexed as

CD4-Positive T-LymphocytesCell FusionCell MembraneGlycolysisHIV-1HumansMembrane FusionPrimary Cell CultureSingle-Cell AnalysisViral Envelope ProteinsVirionVirus InternalizationViral Envelope Proteins

Identifiers

PMID32084246
PMCPMC7055913
OpenAlexW3007311924

What Socratic holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.